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Introduction: Dynamic predictors of fluid responsiveness, namely systolic pressure variation, pulse pressure
variation, stroke volume variation and pleth variability index have been shown to be useful to identify in advance
patients who will respond to a fluid load by a significant increase in stroke volume and cardiac output. As a result,
they are increasingly used to guide fluid therapy. Several randomized controlled trials have tested the ability of
goal-directed fluid therapy (GDFT) based on dynamic parameters (GDFTdyn) to improve post-surgical outcome.
These studies have yielded conflicting results. Therefore, we performed this meta-analysis to investigate whether
the use of GDFTdyn is associated with a decrease in post-surgical morbidity.
Methods: A systematic literature review, using MEDLINE, EMBASE, and The Cochrane Library databases through
September 2013 was conducted. Data synthesis was obtained by using odds ratio (OR) and weighted mean
difference (WMD) with 95% confidence interval (CI) by random-effects model.
Results: In total, 14 studies met the inclusion criteria (961 participants). Post-operative morbidity was reduced by
GDFTdyn (OR 0.51; CI 0.34 to 0.75; P <0.001). This effect was related to a significant reduction in infectious (OR 0.45;
CI 0.27 to 0.74; P = 0.002), cardiovascular (OR 0.55; CI 0.36 to 0.82; P = 0.004) and abdominal (OR 0.56; CI 0.37 to
0.86; P = 0.008) complications. It was associated with a significant decrease in ICU length of stay (WMD −0.75 days;
CI −1.37 to −0.12; P = 0.02).
Conclusions: In surgical patients, we found that GDFTdyn decreased post-surgical morbidity and ICU length of
stay. Because of the heterogeneity of studies analyzed, large prospective clinical trials would be useful to
confirm our findings.Introduction
It has been known for a while that mechanical ventila-
tion may induce cyclic changes in left ventricular stroke
volume and arterial pressure [1]. Many experimental and
clinical studies have demonstrated that the magnitude of
the arterial pressure waveform variation is highly dependent
on blood volume [2]. The idea to use the systolic pressure
variation (SPV) or the pulse pressure variation (PPV) not
only to track changes in blood volume, but also to predict
fluid responsiveness (defined as the hemodynamic response
to a fluid load), emerged 15 years ago [3-5]. Tavernier et al.* Correspondence: benesj@fnplzen.cz
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unless otherwise stated.[5] demonstrated that SPV is a better predictor of fluid re-
sponsiveness than left ventricular end-diastolic area, an
echocardiographic marker of cardiac preload. Michard
et al. [3] demonstrated that PPV is an accurate predictor
of fluid responsiveness, dramatically better than cardiac
filling pressures, and slightly but significantly better than
SPV. Since then, many clinical studies have confirmed the
value of SPV and PPV to predict fluid responsiveness [2].
Others dynamic parameters, mainly the stroke volume
variation (SVV) measured by pulse contour methods [6]
and the pleth variability index (PVI) derived from pulse ox-
imetry [7], have also been proposed and used with success
to predict fluid responsiveness. Today, most hemodynamic
monitors calculate automatically and display these dy-
namic parameters. According to published peer-reviewedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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from 1% in 1998 [8] to 45% in 2012 [9].
If the ability of dynamic parameters to predict fluid re-
sponsiveness is now hardly disputable (pending the limi-
tations to their use being respected), whether their use is
associated with improved quality of care and outcome
remains an open question. In 2007, Lopes et al. [10]
were the first to demonstrate that intra-operative goal-
directed fluid therapy (GDFT) based on PPV monitoring
is able to decrease post-operative complications and hos-
pital length of stay in patients undergoing major abdom-
inal surgery. However, the following year, Buettner et al.
[11] failed to reproduce these results, although their
study design was very similar. Since then, several other
randomized controlled trials (RCTs) have been performed
where fluid therapy was driven by the use of dynamic pa-
rameters. These studies have yielded conflicting results.
Therefore, we performed the present meta-analysis in
order to clarify if GDFT based on dynamic parameters
(GDFTdyn) may decrease post-surgical morbidity when
compared to standard fluid management.
Material and methods
Eligibility criteria
The study was performed in adherence to the PRISMA
statement (for the full PRISMA statement checklist see
the supplemental digital content in Additional file 1)
[12], no ethics board approval was deemed necessary for
a meta-analysis of previously published studies. Eligible
studies were searched according to the following criteria:
Type of participants
Adult (age 18 years or over) patients undergoing surgery
were considered. Studies involving mixed population of
critically ill or non-surgical patients were excluded.
Type of intervention
Intervention was defined as GDFT based on dynamic
parameters (GDFTdyn).
Type of comparison
RCTs comparing the effects of GDFTdyn and standard
fluid management were considered.
Type of outcome measures
The primary outcome measure was post-surgical mor-
bidity. Morbidity was defined as the proportion of patients
with one or more post-surgical complication. The specific
post-surgical infectious, cardiac, respiratory, renal and ab-
dominal complications, as well as ICU and hospital length
of stay were assessed as secondary outcome variables. Ab-
dominal complications included both gastrointestinal and
liver complications.Types of studies
No language, publication date, or publication status re-
strictions were imposed.Information sources
Different search strategies were performed to retrieve rele-
vant studies by using MEDLINE, The Cochrane Library
and EMBASE databases (last update September 2013). No
date restriction was applied for MEDLINE and The
Cochrane Library databases, while the search was limited
to 2006 to 2013 for EMBASE database [13]. Additional tri-
als were searched in The Cochrane Library and in the
DARE databases and the reference lists of previously pub-
lished reviews and retrieved articles.Search
We used the following search terms to search all trials:
randomized controlled trial, controlled clinical trial, goal
directed, goal oriented, goal target, cardiac output, car-
diac index, oxygen delivery, oxygen consumption, car-
diac volume, stroke volume, fluid therapy, fluid loading,
fluid administration, optimization, pulse pressure vari-
ation, pleth variability index, stroke volume variation,
systolic pressure variation. The search strategies used for
MEDLINE, The Cochrane Library and EMBASE data-
bases are shown in the supplemental digital content in
Additional file 2.Study selection
Two investigators (MTG, NB) examined at first each
title and abstract to identify potentially relevant articles.
The eligibility of the retrieved full-text articles was inde-
pendently determined by three investigators (JB, NB,
FM). Only trials where dynamic predictors were used to
titrate fluid administration were considered for analysis.
All identified articles were in English so no text transla-
tions were necessary.Data collection process
Data were independently collected by two investigators
(JB, MTG) with any discrepancy resolved by re-inspection
of the original article. To avoid transcription errors, the
data were input into statistical software and rechecked by
a third investigator (NB).Data items
Data abstraction included number of patients, type of
surgery, dynamic parameter used to guide fluid therapy,
technology used to measure dynamic parameters, type
of fluid administered, as well as the outcome variables
described above.
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The Scottish Intercollegiate Guidelines Network (SIGN)
checklist for RCTs was used to evaluate the methodo-
logical quality of RCTs [14]. The SIGN checklist was inde-
pendently filled by two investigators (MTG, JB) and
whenever different, the study was further assessed in order
to reach consensus. A double plus (++) denotes studies
very unlikely to have bias, a single plus (+) denotes studies
where bias is unlikely, and a minus (−) studies with high
risk of bias. A double plus was assigned to studies that
adequately described all the criteria of randomization,
concealment, blinding, intention-to-treat analysis, and
predefined outcomes, whereas a single plus was given to
studies meeting only four out of the five criteria. The ad-
equacy of these five criteria is strongly associated with
bias reduction [15,16]. With regard to blinding, studies in
which the outcome variables were collected by investiga-
tors not aware of the intra-operative fluid strategy were
considered adequately masked [17].
Summary measures and planned method of analysis
Meta-analytic techniques (analysis software RevMan, ver-
sion 5.2 Cochrane Collaboration, Oxford, England, UK)
were used to combine studies using odds ratios (OR) and
95% confidence intervals (CI) for dichotomous vari-
ables, and weighted mean difference (WMD) and 95% CI
for continuous variables. A statistical difference between
groups was considered to occur if the pooled 95% CI
did not include one for the OR. An OR less than one
favored GDFTdyn when compared with standard fluid
treatment. Two-sided P values were calculated. A random-
effects model was chosen for all analyses. Statistical het-
erogeneity and inconsistency were assessed by using
the Q and I2 tests, respectively [18,19]. When the
P value of the Q-test was <0.10 and/or the I2 was >40%




The search strategies identified 3,297 (MEDLINE), 9,852
(Cochrane Library) and 2,205 (EMBASE) articles. Thirteen
articles were identified through other sources (reference
lists). After initial screening and subsequent selection, a
pool of 105 potentially relevant RCTs was identified. The
subsequent eligibility process (Figure 1) excluded 91 arti-
cles. Among these, in six trials dynamic predictors of fluid
responsiveness were used for GDFT in surgical pa-
tients, but the following reasons precluded their in-
clusion: studies comparing two GDFTdyn approaches
[21-24], or studies comparing GDFTdyn to GDFT based
on flow parameters [25], or studies using GDFTdyn but
without any comparison group [26]. Two meeting
abstracts fulfilled eligibility criteria [27,28], but wereexcluded because of not providing enough information in
regard of methodology and patients outcomes and never
making it to full publication. Overall, 14 articles
[10,11,29-40] with a total sample of 961 patients, were
considered for the analysis.Study characteristics
All selected articles were RCTs evaluating the effects of
GDFTdyn on post-operative complications or length of
stay. All studies were published between 2007 and 2013.
All RCTs but two [30,33] were single-center trials.
Eleven studies included major abdominal procedures,
two cardiac surgeries and one a thoracic procedure.
Eight studies were performed in Europe, three in China
and one in each of the following countries: the United
States, India and Brazil (Table 1).
Missing or uncertain information was gathered by direct
communication with the authors (see Acknowledgements
section). Characteristics concerning the 14 RCTs analyzed
are summarized in Table 1. Dynamic parameters used to
guide fluid therapy were SVV in eight studies, PPV in four
studies, SPV in one study and PVI in one study. SVV was
measured by the FloTrac/Vigileo system (Edwards Life-
sciences, Irvine, CA, USA) in seven studies and by the
PiCCO system (Pulsion Medical Systems SE, Munich,
Germany) in one study, PPV was measured by the bedside
monitor in three studies and the ProAQT/Pulsioflex sys-
tem (Pulsion Medical Systems SE) in one study, SPV was
measured by the bedside monitor and PVI by the Radical
7 pulse oximeter (Masimo Corp, Irvine, CA, USA). The
methodological evaluation, according to the SIGN score,
showed that 10 out of 14 studies were considered as hav-
ing low risk of bias (either ‘++’ or ‘+’ in Table 2).Outcome measures
The overall morbidity rate was obtained from 10 studies
[10,30,32,33,35-40] and a significant reduction was ob-
served in favor of GDFTdyn (OR 0.51; CI 0.34 to 0.75;
P <0.001; I2 = 28%) (Figure 2). A significant reduction
in infectious (OR 0.45; CI 0.27 to 0.74; P = 0.002; I2 =
30%), cardiovascular (OR 0.55; CI 0.36 to 0.82; P = 0.004;
I2 = 0%) and abdominal complications (OR 0.56; CI 0.37
to 0.86; P = 0.008; I2 = 3%) was observed in favor of
GDFTdyn (Figures 3, 4 and 5). A non-significant trend to-
wards a reduction in respiratory complications was ob-
served (0.60; CI 0.33 to 1.09; P = 0.09; I2 = 0%). Renal
complications were not significantly reduced by GDFTdyn
(0.57; CI 0.24 to 1.35; P = 0.20; I2 = 40%).
A significant reduction in ICU length of stay was also
observed (WMD −0.75 days; CI −1.37 to −0.12; P = 0.02;
I2 = 52%) (Figure 6), whereas hospital length of stay did
not significantly decrease (WMD −1.33 days; CI −2.90 to
0.23; P = 0.10; I2 = 78%).
Figure 1 Flow diagram illustrating search strategy. CI: cardiac index; SvO2: central venous saturation; SVV: stroke volume variation.
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Our meta-analysis shows that GDFTdyn decreases post-
surgical morbidity, the rate of infectious, cardiac and ab-
dominal complications, as well as ICU length of stay.
Many post-surgical complications are related, at least in
part, to insufficient or excessive fluid administration dur-
ing the peri-operative period [41]. A U-shaped relation-
ship is classically described between the amount of fluid
administered peri-operatively and the morbidity rate [41].
It has been suggested that giving fluid until patients’ heart
has reached the plateau of the Frank-Starling relationship
may be the most efficient way to prevent both hypovol-
emia and fluid overload. In clinical practice, this approach
consists of giving fluid until flow parameters (stroke vol-
ume or cardiac output) reach a plateau value (to preventhypovolemia), then to stop giving any additional fluid vol-
ume (to prevent fluid overload).
Dynamic predictors of fluid responsiveness are not
markers of blood volume, nor markers of cardiac pre-
load, but markers of the position on the Frank-Starling
curve [2]. In this regard, they have been proposed to
identify when the plateau of the Frank-Starling relationship
is reached without the need to give fluid and to monitor
flow parameters [42]. Several randomized controlled trials
and meta-analyses have demonstrated the superiority of
GDFT based on flow parameters over standard fluid man-
agement to decrease renal, gastrointestinal, respiratory and
infectious complications, as well as the overall morbidity
rate [43-50]. From a physiological standpoint, maximizing
stroke volume or minimizing dynamic parameters with
Table 1 Characteristics of included GDFTdyn studies











Major abdominal High 120 (60/60) Intra SVV <10% CI >2.5 l/min/m2, MAP >65 mmHg,
CVP <15 mmHg,




Major abdominal Moderate 80 (40/40) Intra SPV <10% N/A Fluids Y -
Forget, 2010
[37] Europe
Abdominal Moderate 82 (41/41) Intra PVI <10% MAP >65 mmHg Fluids Y CV, GI, infectious, renal
Goepfert, 2013
[36] Europe
Elective cardiac High 100 (50/50) Intra,
post
SVV <10% CI >2.0 l/min/m2, MAP >65 mmHg,
HR 50-100 bpm, EVLWI ≤12 ml/kg









Cardiac High 27 (14/13) Intra,
post
SVV <10% CI >2.5 mL/min/m2, CVP >6 mmHg,





Fluids, inotropes Y GI, CV, renal, respiratory
Lopes, 2007
[10] Brazil




Major abdominal High 60 (30/30) Intra SVV <12% CI >2.5 mL/min/m2, MAP >65 mmHg,
SVI >35 ml/m2
Fluids, inotropes Y Renal, respiratory
Ramsingh, 2013
[34] USA
Major abdominal High 38 (20/18) Intra SVV <13% N/A Fluids N -
Salzwedel, 2013
[30] Europe












Thoracic Moderate 60 (30/30) Intra SVV <9% CI >2.5 mL/min/m2, MAP >65 mmHg Fluids, inotropes N GI, infectious, renal, Respiratory
Zheng, 2013
[29] China
Elective abdominal Moderate 60 (30/30) Intra,
post
SVV <12% CI >2.5 mL/min/m2, MAP >65 mmHg,
SVI >35 ml/m2
Fluids, inotropes N CV, GI
*Number of participants displayed as overall (control/intervention); complications. GDFTdyn: goal-directed fluid therapy based on dynamic parameters; SVV: stroke volume variation; CV: cardiovascular; GI: abdominal
(gastrointestinal/liver); MAP: mean arterial pressure; CVP: central venous pressure; SPV: systolic pressure variation; N/A, not available; PVI: pleth variability index; CI: cardiac index; HR, heart rate; EVLWI: extravascular lung












Table 2 Risk of bias assessed using the SIGN score
Study SIGN score SIGN comment
Benes, 2010 [38] Europe ++ -
Buettner, 2008 [11] Europe - Blinding and concealment not clear
Forget, 2010 [37] Europe ++ -
Goepfert, 2013 [36] Europe ++ -
Harten, 2008 [35] Europe - Blinding not clear, outcomes not defined
Kapoor, 2008 [39] India - Randomization and blinding not clear, outcomes not defined
Lopes, 2007 [10] Brazil ++ -
Mayer, 2010 [40] Europe + Randomization not clear
Ramsingh, 2013 [34] USA + Intention-to-treat analysis not performed.
Salzwedel, 2013 [30] Europe ++ Multicentric trial
Sheeren, 2013 [33] Europe + Intention-to-treat analysis not performed, multicentric trial
Zhang Ju, 2012 [32] China + Intention-to-treat analysis not performed
Zhang Ji, 2013 [31] China - Randomization and blinding not clear, outcomes not defined
Zheng, 2013 [29] China ++ -
SIGN: The Scottish Intercollegiate Guidelines Network.
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benefits when using dynamic parameters than when using
flow parameters to guide fluid therapy. This is what our
meta-analysis does confirm: clinical benefits of GDFTdyn
are comparable to those reported with GDFT based on
flow parameters [46,51].
Fuelled by the growing number of clinical studies and
meta-analyses demonstrating the value of GDFT, official
recommendations have been published [52]. However,
despite these recommendations, adoption of GDFT re-
mains poor [53]. A recent survey showed that a minority
of anaesthetists use GDFT in patients undergoing high-
risk surgery, whereas they believe they should [9].
For GDFT, the use of dynamic parameters has several
potential advantages over the use of flow parameters. First,
it has the advantage of being simple, whereas the use of
flow parameters requires interventions and calculations.Figure 2 Forest plot for post-surgical morbidity.For instance, the stroke volume fluid optimization strat-
egy, currently recommended both in the UK and in France
[54,55], requires the assessment and quantification of the
percentage change in stroke volume during a standardized
fluid challenge. Oxygen delivery optimization strategies
require intermittent calculations of the oxygen delivery
index based on the simultaneous measurement of cardiac
output, hemoglobin and arterial oxygen saturation by dif-
ferent devices. As a result, fluid strategies based on flow
parameters are often perceived as complex and time-
consuming by caregivers. In contrast, using dynamic pa-
rameters does not require any intervention to know if
the patient is a fluid responder or not (a high SPV, PPV,
SVV or PVI value suggests that the patient is fluid respon-
sive), nor any calculations (delta change in stroke volume,
oxygen delivery). Caregivers simply have to monitor dy-
namic parameters and ensure the value remains below a
Figure 3 Forest plot for infectious complications.
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plicity may be a key element to expand the clinical adop-
tion of GDFT. Second, using dynamic parameters may be
considered as a cost-saving approach. Indeed, although
SVV measurement requires the use of a cardiac output
monitor, the estimation of PPV is possible from any bed-
side monitor displaying an arterial pressure curve. Of
note, the mere eyeballing of the respiratory swings in ar-
terial pressure may be misleading such that a real quantifi-
cation of this phenomenon is required [2]. A minority of
monitors currently in use in operating rooms have the
ability to automatically calculate PPV. Freezing the arterial
pressure tracing, and measuring systolic and diastolic
pressures beat by beat to identify the maximum and mini-
mum pulse pressure values over a single respiratory cycle
is a real but time-consuming alternative to the automatic
calculation of PPV.
The use of dynamic parameters has also disadvantages.
The main disadvantage is the fact that they cannot beFigure 4 Forest plot for cardiovascular complications.used in many patients because of limitations, which have
been described in detail elsewhere [2], and do include
small tidal volume (<8 ml/kg), open chest, sustained car-
diac arrhythmia and abdominal hypertension (for example
laparoscopy) [56]. A study [57] looking at more than
12,000 non-cardiac surgical patients concluded that, given
their limitations, dynamic parameters could have been
used to guide fluid therapy in only 39% of the cases, the
most frequent limitation being the use of a small tidal vol-
ume for mechanical ventilation (one-third of the cases in
this specific study). To decrease the risk of ventilation-
induced lung injury, clinicians have lowered tidal volumes,
not only in patients with respiratory failure, but also in pa-
tients with healthy lungs undergoing surgery. A recent
study by Futier et al. [58] shows that using tidal volumes
of 6 to 8 ml/kg during abdominal surgery is associated
with a better post-operative outcome than when using a
tidal volume of 10 to 12 ml/kg. If such low tidal volumes
(6 to 8 ml/kg) were to be adopted widely to ventilate
Figure 5 Forest plot for abdominal complications.
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decrease the applicability of dynamic parameters for
GDFT. However, this study [58] does not disqualify the
use of intermediate tidal volumes (8 to 10 ml/kg) that
would be compatible with the use of dynamic parameters
for GDFT.
The main limitation of our study is the heterogeneity
of the randomized controlled trials we analyzed. First,
we observed a statistical (the Q and I2 tests) heterogen-
eity and inconsistency among studies investigating the
effects of GDFTdyn on ICU and hospital length of stay,
as well as on renal function. Previous meta-analyses have
shown a significant reduction in renal insufficiency with
GDFT [43]. A benefit has also been reported for hospital
length of stay, with a reduction ranging between one and
two days [51,59]. In contrast, previous meta-analyses
failed to demonstrate a decrease in ICU length of stay.
Therefore, the effect or lack of effect of GDFTdyn on ICU
and hospital length of stay, as well as on renal function,
deserves further investigation before drawing any defini-
tive conclusion. Beside the heterogeneity detected by stat-
istical tests, one must acknowledge that the randomized
controlled trials were also different with regard to theFigure 6 Forest plot for ICU length of stay.definition of post-surgical complications. Unfortunately,
there is no universal definition for post-surgical com-
plications such as bacterial pneumonia (protected or
non-protected bacteriological samples) or acute renal
insufficiency (oliguria or increase in creatinine level), and
this certainly contributes to the heterogeneity of the stud-
ies we analyzed. If fluid management was always based on
the monitoring of dynamic parameters, different trigger
values, ranging from 9 to 13% (Table 1), were used to give
fluid. In addition, some hemodynamic protocols included
additional static parameters such as blood pressure and
cardiac output (Table 1). The heterogeneity among treat-
ment protocols and definition of complications is a com-
mon feature of previous GDFT meta-analyses [43-50], but
it is important to bear in mind that it may have influenced
our findings.
Conclusion
Our meta-analysis suggests that GDFTdyn decreases post-
surgical morbidity, infectious, cardiac and abdominal
complications, as well as ICU length of stay. Pending limi-
tations to their use being understood and respected, dy-
namic parameters may represent an alternative to flow
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of the heterogeneity of studies analyzed, large prospective
clinical trials would be useful to confirm our findings.
Key messages
 We analyzed 14 randomized controlled trials
investigating the value of goal-directed fluid therapy
(GDFT) based on dynamic parameters (GDFTdyn)
to improve post-surgical outcome.
 Our meta-analysis showed that GDFTdyn is associated
with a significant decrease in post-surgical morbidity,
defined as the proportion of patients developing one
or more complication.
 This decrease in post-surgical morbidity was related
to a significant reduction in infectious, cardiovascular,
and abdominal complications and was associated with
decrease in ICU length of stay.
 GDFTdyn may be an interesting alternative to
classical GDFT strategies, which are based on flow
parameters such as cardiac output or oxygen
delivery.Additional files
Additional file 1: PRISMA checklist.
Additional file 2: Search strategies.
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